<DOC>
	<DOCNO>NCT02127307</DOCNO>
	<brief_summary>This aim study investigate prognostic usefulness AdreView™ image identify subject New York Heart Association ( NYHA ) Class II III HF die 60 month follow-up date administration AdreView™ prior study MBG311 , MBG312 , MBG312C ( hereafter include MBG312 ) .</brief_summary>
	<brief_title>Phase 4 Study Demonstrate Prognostic Usefulness AdreView™ Scintigraphy Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up .</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>The subject HF subject sign informed consent MBG311 MBG312 . The subject administer AdreView™ MBG311 MBG312 . The subject complete late planar image assessment ( minimum ) require protocol MBG311 MBG312 , image read judge diagnostic least 2 blind reader . In addition , subject must meet 1 follow 3 inclusion criterion . If subject locate , he/she provide informed consent allow investigator access medical record and/or give permission investigator speak treat physician . If subject locate he/she decline provide inform consent , IRB/EC provide waiver consent allow investigator record subject alive . If subject locate , IRB/EC provide waiver consent allow investigator access available medical record care provide subsequent last date subject participation MBG311 , MBG312 , and/or MBG313 and/or allow collection data publicly available source . The subject withdraw withdrawn MBG311 MBG312 protocol violation . The subject underwent heart transplantation MBG311 , MBG312 , MBG313 . The subject record died MBG311 , MBG312 , MBG313 . The subject voluntarily withdraw MBG311 , MBG312 , MBG313 , IRB/EC provide waiver allow record subject survival status instance . The subject locate , contact , information find establish survival status beyond date last contact MBG311 , MBG312 , MBG313 , include information available result IRB/ECapproved waiver .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Myocardial sympathetic innervation</keyword>
	<keyword>Heart failure ( HF )</keyword>
	<keyword>Nuclear image</keyword>
	<keyword>Radiopharmaceutical</keyword>
</DOC>